Enhancement of in vivo targeting properties of ErbB2 aptamer by chemical modification

Enhancement of in vivo targeting properties of ErbB2 aptamer by chemical modification

Show other versions (1)

Bibliographic Details
Main Authors:	Jun Young Park, Ye Lim Cho, Ju Ri Chae, Jung Hwan Lee, Won Jun Kang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511116/?tool=EBI

Similar Items

Enhancement of in vivo targeting properties of ErbB2 aptamer by chemical modification.
by: Jun Young Park, et al.
Published: (2023-01-01)

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020-06-01)

Computational modeling of ErbB kinase oligomeric state.
by: Lim, Sing Mei.
Published: (2010)

The role of protease activity in ErbB biology.
by: Blobel, C, et al.
Published: (2009)

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
by: Mizobuchi S, et al.
Published: (2013-02-01)

Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis
by: Yun Liu, et al.
Published: (2023-05-01)

ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells
by: Bo-Kyeong Jung, et al.
Published: (2022-06-01)

Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer
by: Jun Young Park, et al.
Published: (2020-10-01)

Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
by: Kranthi Kumar Chougoni, et al.
Published: (2023-11-01)

The Mysterious Ways of ErbB2/HER2 Trafficking
by: Vibeke Bertelsen, et al.
Published: (2014-08-01)

Alterations of neuregulin1 and ErbB4 expression in the cerebellum in schizophrenia
by: Law, A, et al.
Published: (2005)

Expression of c-erbB3 protein in primary breast carcinomas.
by: Naidu, R., et al.
Published: (1998)

The ErbB Signaling Network and Its Potential Role in Endometrial Cancer
by: Georgios Androutsopoulos, et al.
Published: (2023-10-01)

Quantitative modeling perspectives on the ErbB system of cell regulatory processes
by: Lazzara, Matthew J., et al.
Published: (2010)

Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation
by: Atiqur Rahman, et al.
Published: (2019-10-01)

Investigation of ErbB and Insulin Signaling Pathways in the Pathogenesis of Multiple Myeloma
by: Derya Öztürk, et al.
Published: (2018-06-01)

Clinicopathological value of ErbB2 gene and protein expression in osteochondroma
by: Zhen Huang, et al.
Published: (2020-01-01)

Characterisation of Neuregulin1 and ErbB4 protein expression in the human brain
by: Law, A, et al.
Published: (2003)

Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama
by: Igor E. Eliseev, et al.
Published: (2021-08-01)

Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
by: Emilia Rabia, et al.
Published: (2023-04-01)

Irreversible tyrosine kinase inhibitors induce the endocytosis and downregulation of ErbB2
by: Chinmoy Ghosh, et al.
Published: (2023-07-01)

Cartilage regeneration in zebrafish depends on Nrg1/ErbB signaling pathway
by: Dora Sapède, et al.
Published: (2023-04-01)

Sistema Neuregulina1/ErbB: importância no controlo da função cardíaca.
by: Luisa Lopes-Conceição, et al.
Published: (2011-12-01)

Engineered Bivalent Ligands to Bias ErbB Receptor-mediated Signaling and Phenotypes
by: Jay, Steven M., et al.
Published: (2012)

Tailoring Chimeric Ligands for Studying and Biasing ErbB Receptor Family Interactions
by: Krueger, Andrew T., et al.
Published: (2015)

Molecular markers (c-erbB-2, p53) in breast cancer.
by: Piotr Zukrowski, et al.
Published: (2009-01-01)

ErbB4 in laminated brain structures: a neurodevelopmental approach to schizophrenia
by: Carlos Gustavo Perez-Garcia
Published: (2015-12-01)

Differences in the binding affinities of ErbB family : heterogeneity in the prediction of resistance mutants
by: Verma, Chandra S., et al.
Published: (2014)

Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
by: Gillian Farnie, et al.
Published: (2013-01-01)

A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2<sup>+</sup> Solid Cancer
by: Andreas A. Hombach, et al.
Published: (2023-01-01)

DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
by: Wen-Chieh Liao, et al.
Published: (2018-01-01)

c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study.
by: Soomro, S, et al.
Published: (1993)

Understanding the role of Neuregulin 1-erbB signalling in microglia in the context of neuropathic pain.
by: Sikander, S
Published: (2015)

Altered ErbB3 receptor mRNA in the dorsolateral prefrontal cortex in schizophrenia
by: Beltaifa, S, et al.
Published: (2005)

c-erbB-2 expression in different histological types of invasive breast carcinoma.
by: Soomro, S, et al.
Published: (1991)

Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer
by: Terry W. Moody, et al.
Published: (2023-07-01)

Bispecific Antibodies for IFN-β Delivery to ErbB2<sup>+</sup> Tumors
by: Vladislav S. Rybchenko, et al.
Published: (2021-12-01)

Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models
by: Raman Devarajan, et al.
Published: (2023-09-01)

ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
by: Jiang Yu, et al.
Published: (2023-10-01)

ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component
by: Suvi Jauhiainen, et al.
Published: (2023-05-01)